Proposal for a Guideline of Risk Reduction and Sensitivity Optimization in Imaging Tests for People with Diabetes

Detalhes bibliográficos
Autor(a) principal: Donato, Sara
Data de Publicação: 2021
Outros Autores: Simões, Helder, Donato, Paulo
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486
Resumo: Diabetes is a very common chronic disease in the Portuguese population, with an estimated prevalence of 13.6% in the adults. Doubts often arise regarding the best preparation and the risks associated with doing imaging tests in these patients. In this article we intend to review the main precautions in imaging tests in people with diabetes and to suggest a guideline to reduce the risks and optimize the sensitivity of these tests in this population. The main topics addressed in this article are the need to suspend metformin after the administration of endovascular iodinated contrast due to the risk of lactic acidosis, the precautions in insulin-treated patients or those taking medicines with a higher risk of hypoglycemia when performing imaging tests that require fasting, and the influence of hyperglycemia and of anti-diabetic therapy on the sensitivity of PET-FDG. With this review and the presentation of a guideline, we intend to demystify and simplify the management of individuals with diabetes who are undergoing imaging tests.
id RCAP_f9f941102ea7305c9faaf1f2ebda223a
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/15486
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Proposal for a Guideline of Risk Reduction and Sensitivity Optimization in Imaging Tests for People with DiabetesProposta de Protocolo para Redução dos Riscos e Otimização da Sensibilidade nos Exames de Imagem em Pessoas com DiabetesContrast MediaDiabetes MellitusType 1Type 2Diagnostic ImagingPositron-Emission TomographyDiabetes Mellitus Tipo 1Diabetes Mellitus Tipo 2Diagnóstico por ImagemMeios de ContrasteTomografia com Emissão de PositrõesDiabetes is a very common chronic disease in the Portuguese population, with an estimated prevalence of 13.6% in the adults. Doubts often arise regarding the best preparation and the risks associated with doing imaging tests in these patients. In this article we intend to review the main precautions in imaging tests in people with diabetes and to suggest a guideline to reduce the risks and optimize the sensitivity of these tests in this population. The main topics addressed in this article are the need to suspend metformin after the administration of endovascular iodinated contrast due to the risk of lactic acidosis, the precautions in insulin-treated patients or those taking medicines with a higher risk of hypoglycemia when performing imaging tests that require fasting, and the influence of hyperglycemia and of anti-diabetic therapy on the sensitivity of PET-FDG. With this review and the presentation of a guideline, we intend to demystify and simplify the management of individuals with diabetes who are undergoing imaging tests.A diabetes é uma doença crónica muito frequente na população portuguesa, sendo a sua prevalência estimada de 13,6% nos adultos. A melhor preparação e os riscos associados à realização de exames de imagem em pessoas com diabetes são frequentemente objeto de dúvidas. Neste artigo, pretendemos rever as principais precauções e sugerir um protocolo de atuação, de forma a reduzir os riscos e otimizar a sensibilidade destes exames nesta população. Revemos também a necessidade de suspensão de metformina após a administração de contraste iodado endovascular, pelo risco de acidose láctica, as precauções em pessoas com diabetes insulinotratadas ou sob fármacos que apresentam maior risco de hipoglicemia na realização de exames de imagem que obriguem a jejum, e a influência da hiperglicemia e da terapêutica anti-diabética na sensibilidade da PET-FDG. Com a revisão deste tema e apresentação de um protocolo de atuação pretendemos desmistificar a orientação dos indivíduos com diabetes que vão ser submetidos a exames de imagem, tornando mais simples a sua gestão.Ordem dos Médicos2021-05-02info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486oai:ojs.www.actamedicaportuguesa.com:article/15486Acta Médica Portuguesa; Vol. 34 No. 5 (2021): May; 388-394Acta Médica Portuguesa; Vol. 34 N.º 5 (2021): Maio; 388-3941646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486/6324https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486/13072https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486/13075https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486/13330Direitos de Autor (c) 2021 Acta Médica Portuguesa - Ordem dos Médicosinfo:eu-repo/semantics/openAccessDonato, SaraSimões, HelderDonato, Paulo2022-12-20T11:07:33Zoai:ojs.www.actamedicaportuguesa.com:article/15486Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:20:39.196174Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Proposal for a Guideline of Risk Reduction and Sensitivity Optimization in Imaging Tests for People with Diabetes
Proposta de Protocolo para Redução dos Riscos e Otimização da Sensibilidade nos Exames de Imagem em Pessoas com Diabetes
title Proposal for a Guideline of Risk Reduction and Sensitivity Optimization in Imaging Tests for People with Diabetes
spellingShingle Proposal for a Guideline of Risk Reduction and Sensitivity Optimization in Imaging Tests for People with Diabetes
Donato, Sara
Contrast Media
Diabetes Mellitus
Type 1
Type 2
Diagnostic Imaging
Positron-Emission Tomography
Diabetes Mellitus Tipo 1
Diabetes Mellitus Tipo 2
Diagnóstico por Imagem
Meios de Contraste
Tomografia com Emissão de Positrões
title_short Proposal for a Guideline of Risk Reduction and Sensitivity Optimization in Imaging Tests for People with Diabetes
title_full Proposal for a Guideline of Risk Reduction and Sensitivity Optimization in Imaging Tests for People with Diabetes
title_fullStr Proposal for a Guideline of Risk Reduction and Sensitivity Optimization in Imaging Tests for People with Diabetes
title_full_unstemmed Proposal for a Guideline of Risk Reduction and Sensitivity Optimization in Imaging Tests for People with Diabetes
title_sort Proposal for a Guideline of Risk Reduction and Sensitivity Optimization in Imaging Tests for People with Diabetes
author Donato, Sara
author_facet Donato, Sara
Simões, Helder
Donato, Paulo
author_role author
author2 Simões, Helder
Donato, Paulo
author2_role author
author
dc.contributor.author.fl_str_mv Donato, Sara
Simões, Helder
Donato, Paulo
dc.subject.por.fl_str_mv Contrast Media
Diabetes Mellitus
Type 1
Type 2
Diagnostic Imaging
Positron-Emission Tomography
Diabetes Mellitus Tipo 1
Diabetes Mellitus Tipo 2
Diagnóstico por Imagem
Meios de Contraste
Tomografia com Emissão de Positrões
topic Contrast Media
Diabetes Mellitus
Type 1
Type 2
Diagnostic Imaging
Positron-Emission Tomography
Diabetes Mellitus Tipo 1
Diabetes Mellitus Tipo 2
Diagnóstico por Imagem
Meios de Contraste
Tomografia com Emissão de Positrões
description Diabetes is a very common chronic disease in the Portuguese population, with an estimated prevalence of 13.6% in the adults. Doubts often arise regarding the best preparation and the risks associated with doing imaging tests in these patients. In this article we intend to review the main precautions in imaging tests in people with diabetes and to suggest a guideline to reduce the risks and optimize the sensitivity of these tests in this population. The main topics addressed in this article are the need to suspend metformin after the administration of endovascular iodinated contrast due to the risk of lactic acidosis, the precautions in insulin-treated patients or those taking medicines with a higher risk of hypoglycemia when performing imaging tests that require fasting, and the influence of hyperglycemia and of anti-diabetic therapy on the sensitivity of PET-FDG. With this review and the presentation of a guideline, we intend to demystify and simplify the management of individuals with diabetes who are undergoing imaging tests.
publishDate 2021
dc.date.none.fl_str_mv 2021-05-02
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486
oai:ojs.www.actamedicaportuguesa.com:article/15486
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/15486
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486/6324
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486/13072
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486/13075
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15486/13330
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2021 Acta Médica Portuguesa - Ordem dos Médicos
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2021 Acta Médica Portuguesa - Ordem dos Médicos
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 34 No. 5 (2021): May; 388-394
Acta Médica Portuguesa; Vol. 34 N.º 5 (2021): Maio; 388-394
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130654988828672

Registros relacionados